Headquartered in Bethlehem, Pennsylvania, OraSure Technologies is a global leader focused on providing innovative diagnostic solutions with value to existing and emerging healthcare needs. With a goal of improving health and wellness by providing access to accurate and essential information, OraSure has become widely recognized throughout the industry for its manufacturing and distribution of point-of-care diagnostic tests, molecular collection devices, and other technologies that detect or diagnose critical medical conditions.
OraSure's extensive line of innovative products includes everything from rapid rests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuickTM platform, to sample self-collection and stabilization products for molecular applications, to oral fluid laboratory tests for detecting drugs of abuse, and more.
In addition to selling to consumers, like you, OraSure's products are sold across the globe to a wide variety of clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities.
OraSure OraQuick Advance Rapid HIV Test Kit
Designed to detect both HIV-1 and HIV-2 antibodies in as little as 20 minutes, the Oraquick Advance Rapid HIV kit is 99% accurate with 99.9% specificity from "real world" data. The complete kit is compatible with multiple specimen types such as oral fluid, fingerstick and venipuncture whole blood, and plasma. Plus, the high positive value leads to minimal false positives.
OraSure OraQuick HCV Rapid Antibody Test
Boasting greater than 98% accuracy, the OraQuick HCV Rapid Antibody Test is incredibly simple and easy-to-use and provides point of care testing in as little as 20 minutes. The test can be used in locations like public health settings, physician offices, community-health clinics, laboratories, emergency rooms, and more. And, it even allows for oral, fluid, fingerstick, or venipuncture whole blood, serum, or plasma collection.
OraSure Q.E.D. A150
FDA-cleared, the Q.E.D. A150 is a saliva alcohol test that is also CLIA-waived and DOT-approved making it one of the best tests available on the market today. With a 98% correlation to blood gas chromatography and precise quantitative results, this top-of-the-line test is proven accurate. Results are presented in as little as two minutes.
Our Current Specials
At MFI, we work with manufacturers to get the best deals for customers and caregivers. Check out our specials page and get the latest available deals for all types of medical products.